- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04749199
Enhanced Mirror Therapy for Improving Brain Reorganization and Function in Stroke
February 10, 2021 updated by: Stanley John Winser, The Hong Kong Polytechnic University
Enhanced Mirror Therapy for Improving Brain Reorganization and Function in Stroke: A Pilot Randomized Controlled Trial With Economic Evaluation
This research aims to test the methodological procedures and obtain preliminary results regarding the therapeutic and cost-effectiveness of enhanced mirror therapy relative to standard mirror therapy for improving brain reorganization and upper limb function in individuals with stroke.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Stroke is among the leading causes of mortality and disability, worldwide.
Muscle weakness and other complications associated with stroke can result in decreased quality of life and significant declines in the activities of daily living.
Mirror therapy has been shown to have a moderate effect, facilitating the functional recovery among individuals who have experienced a stroke.
A prototype for a computerized, mirror therapy device was developed and found to be feasible.
Recently, the investigators published a critical review and an activation likelihood estimation (ALE) meta-analysis analysing the widespread reports of brain activity associated with mirror therapy.
Observations using functional near-infrared spectroscopy (fNIRS) to evaluate a group of people with stroke (n = 14) and healthy volunteers (n = 18) revealed that performing complex tasks during the mirror therapy paradigm enhanced top-down motor facilitation in the ipsilesional/ipsilateral hemisphere relative to the moving limb.
An important next step in this series of studies is to evaluate the training effects associated with the performance of complex tasks during mirror therapy among stroke patients, using the designed computerized mirror therapy device to deliver the enhanced mirror therapy training.
The results of this study will help the investigators to understand the underlying mechanisms through which mirror therapy facilitates motor rehabilitation and will add to the body of literature describing the best, evidence-based practices for mirror therapy during stroke rehabilitation.
The investigators propose a pilot study (n = 30) to test the methodological procedures and obtain preliminary results for a fully powered, randomized, controlled trial (RCT), combined with economic evaluation, to compare the therapeutic and cost-effectiveness between standard mirror therapy and enhanced (complex task and blurred image) mirror therapy.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stanley John Winser
- Phone Number: 27666746
- Email: stanley.j.winser@polyu.edu.hk
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adults with stroke (40-75 years old), with normal or corrected-to-normal vision and hearing;
- post-stroke duration of ≥ 6 months, before the start of data collection;
- no severe deficits in memory, communication, or the ability to understand verbal instructions.
Exclusion Criteria:
- participants with recurrent stroke; and
- those who score < 24 on the Mini-Mental State Examination (MMSE).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Enhanced mirror therapy group
Participants in this group will perform complex and randomized finger opposition and reposition movements based on the training protocol, along with enhanced complexity and altered clarity of the displayed image.
|
Participants of the enhanced mirror therapy group will perform complex, randomized, finger opposition and reposition movements, using the thumb, index, middle, ring, and little fingers, and will be shown a 35% blurred visual feedback through the computerized mirror therapy device.
Each participant will receive a mirror training session for 60 minutes each day, three times per week for four consecutive weeks.
Other Names:
|
|
Sham Comparator: Standard mirror therapy group
Participants in this group will perform simple and sequential finger opposition and reposition movements, along with a clear image showing the exercising hand of the participants.
|
Participants allocated to this group will perform simple, sequential finger opposition and reposition movements, using the thumb, index, middle, ring, and little fingers, and will be shown a clear image of the exercising hand.
Each participant will receive a mirror training session for 60 minutes each day, three times per week for four consecutive weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood oxygenated haemoglobin concentrations
Time Frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
Functional near-infrared spectroscopy (fNIRS) will be used to assess neurovascular changes (blood oxygenated haemoglobin concentrations) in the M1.
Higher the score obtained indicate better facilitation of the primary motor cortex.
|
Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wrist and hand function
Time Frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
The Fugl-Meyer assessment (wrist and hand subcomponents) for the assessment of the upper limb function.
The scale has a maximum score of 66 and a minimum of 34 with higher the score obtained better the wrist and hand function.
|
Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
|
Upper limb function
Time Frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
The Action Research Arm Test (ARAT), to assess upper-limb function.
The ARAT scores range from 0-57, with a maximum score of 57 points indicating better performance of the upper limb.
|
Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
|
Economic evaluation
Time Frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
The Euro quality of life (EuroQol, 5 dimensions and 5 levels 62) survey, will assess the quality-adjusted life years (QALY) for the cost-effectiveness estimation.
The EQ-5D-5L response will be converted into utility scores, which will be used to estimate gains or losses in quality-adjusted life-years (QALYs) over the follow-up period.
The higher the score obtained better the quality-life-adjusted-years due to the intervention.
|
Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Stanley John Winser, Hong Kong Polytechnic University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2021
Primary Completion (Anticipated)
December 1, 2021
Study Completion (Anticipated)
November 1, 2022
Study Registration Dates
First Submitted
December 3, 2020
First Submitted That Met QC Criteria
February 9, 2021
First Posted (Actual)
February 11, 2021
Study Record Updates
Last Update Posted (Actual)
February 15, 2021
Last Update Submitted That Met QC Criteria
February 10, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MT-fNIRSstudy
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Enhanced mirror therapy
-
Olga Del Pozo BlancoHospital Universitario La Fe; University Rovira i VirgiliCompletedCarpal Tunnel SyndromeSpain
-
The Hong Kong Polytechnic UniversityRecruiting
-
Istanbul Medipol University HospitalCompleted
-
Asia UniversityEnrolling by invitationStroke | Hemiparesis After StrokeTaiwan
-
Başakşehir Çam & Sakura City HospitalCompletedStroke | Complex Regional Pain Syndrome I (CRPS I) | Mirror TherapyTurkey (Türkiye)
-
The Hong Kong Polytechnic UniversityTung Wah Hospital; Guangdong 999 Brain HospitalCompletedThe Effects of Mirror Therapy on Patients With Unilateral Neglect After Stroke
-
CEU San Pablo UniversityCompleted
-
Universitat Internacional de CatalunyaEnrolling by invitationHemiplegic Cerebral Palsy | Mirror Movement TherapySpain
-
Seoul National University HospitalSeoul National UniversityCompleted
-
Chang Gung Memorial HospitalRecruiting